Cargando…

Symptomatic Improvement of Gastroparesis with Granisetron Transdermal System

Detalles Bibliográficos
Autor principal:	Jung, Hye-Kyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Neurogastroenterology and Motility 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056563/ https://www.ncbi.nlm.nih.gov/pubmed/27703112 http://dx.doi.org/10.5056/jnm16150

Ejemplares similares

Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study
por: Midani, Deena, et al.
Publicado: (2016)

Enhanced Transdermal Delivery of Granisetron by Using Iontophoresis
por: Panzade, Prabhakar, et al.
Publicado: (2012)

Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review
por: Tuca, Albert
Publicado: (2009)

Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management
por: Mason, Jay W, et al.
Publicado: (2013)

Population pharmacokinetic analysis of transdermal granisetron in healthy Chinese and Caucasian volunteers
por: Li, Jiayu, et al.
Publicado: (2023)

Toward an Improved Treatment for Gastroparesis
por: Kim, Tae-Han
Publicado: (2020)

Diabetic Gastroparesis
por: Kalra, Sanjay, et al.
Publicado: (2018)

Use of transdermal and intravenous granisetron and the ability of the Hesketh score to assess nausea and vomiting induced by multiday chemotherapy
por: Boccia, Ralph V, et al.
Publicado: (2012)

Efficacy of the granisetron transdermal system for the control of nausea and vomiting induced by highly emetogenic chemotherapy: a multicenter, randomized, controlled trial
por: Sun, Der Sheng, et al.
Publicado: (2023)

Macrophages: The Missing Link in Diabetic Gastroparesis?
por: Srinivasan, Shanthi
Publicado: (2015)

Comparison of granisetron alone and granisetron plus dexamethasone in the prophylaxis of cytotoxic-induced emesis.
por: Carmichael, J., et al.
Publicado: (1994)

Pharmacotherapy for Gastroparesis: An Attempt to Evaluate a Safer Alternative
por: Ghoshal, Uday C
Publicado: (2010)

Gastroparesis in Asia: An Area Still Unfamiliar to Asian Gastroenterologists
por: Lee, Kang Nyeong
Publicado: (2021)

Gastroparesis
por: Miles, Matthew, et al.
Publicado: (2023)

Gastroparésie
por: Miles, Matthew, et al.
Publicado: (2023)

Dose finding study of granisetron in patients receiving high-dose cisplatin chemotherapy. The Granisetron Study Group.
por: Riviere, A.
Publicado: (1994)

Prevalence of Hidden Gastroparesis in the Community: The Gastroparesis "Iceberg"
por: Rey, Enrique, et al.
Publicado: (2012)

Gastroparesis in children
por: Saliakellis, Efstratios, et al.
Publicado: (2013)

The Incidence, Prevalence, and Survival of Gastroparesis in Olmsted County, Minnesota, 1996-2006 (Gastroenterology 2009;136:1225-1233)
por: Jung, Hye-Kyung
Publicado: (2010)

Clinical predictors of symptom improvement failure in gastroparesis
por: Amjad, Waseem, et al.
Publicado: (2022)

Granisetron versus Granisetron-Dexamethasone for Prevention of Postoperative Nausea and Vomiting in Pediatric Strabismus Surgery: A Randomized Double-Blind Trial
por: Sinha, Renu, et al.
Publicado: (2016)

Postoperative nausea and vomiting prophylaxis: A comparative study of ondansetron, granisetron and granisetron and dexamethasone combination after modified radical mastectomy
por: Gupta, Pushplata, et al.
Publicado: (2014)

Management of Diabetic Gastroparesis
por: Aljarallah, Badr M.
Publicado: (2011)

Mirtazapine for Refractory Gastroparesis
por: Marella, Hemnishil K., et al.
Publicado: (2019)

Norovirus-induced Gastroparesis
por: Sawin-Johnson, Kaylyn N, et al.
Publicado: (2019)

Recent Advances in the Pathophysiology and Treatment of Gastroparesis
por: Oh, Jung Hwan, et al.
Publicado: (2013)

Comparison the Effect of Granisetron and Dexamethasone on Intravenous Propofol Pain
por: Adinehmehr, Leili, et al.
Publicado: (2018)

Relamorelin in Gastroparesis and Diabetic Gastroparesis: A Meta-Analysis on Its Efficacy and Safety
por: Patel, Akash, et al.
Publicado: (2023)

Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective study
por: Wakasugi, Yoshinori, et al.
Publicado: (2019)

The control of acute cisplatin-induced emesis--a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Granisetron Study Group.
por: Chevallier, B.
Publicado: (1993)

Punching and Electroporation for Enhanced Transdermal Drug Delivery
por: Yang, Guang, et al.
Publicado: (2018)

Reconciling Quality by Design and Transdermal Product Development
por: Miller, Kenneth
Publicado: (2020)

Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study
por: Boccia, Ralph V., et al.
Publicado: (2010)

Carbon monoxide contributes to the constipating effects of granisetron in rat colon
por: Nacci, Carmela, et al.
Publicado: (2016)

Influence of serotonin on the analgesic effect of granisetron on temporomandibular joint arthritis.
por: Voog, Ulle, et al.
Publicado: (2004)

Domperidone/granisetron/metoclopramide: Long QT syndrome: case report
Publicado: (2022)

Diabetic gastroparesis: Therapeutic options
por: Alam, Uazman, et al.
Publicado: (2010)

Gastroparesis: Current Concepts and Management
por: Masaoka, Tatsuhiro, et al.
Publicado: (2009)

Gastric Electrical Stimulation for Gastroparesis
por: Soffer, Edy E
Publicado: (2012)

Gastroparesis associated with Juvenile Dermatomyositis
por: Martin, N, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_vc2p2a4e8nerkvroch1b7651am